Our Take On Exelixis, Inc.'s (NASDAQ:EXEL) CEO Salary

Michael Morrissey became the CEO of Exelixis, Inc. (NASDAQ:EXEL) in 2010. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider growth that the business demonstrates. And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. This process should give us an idea about how appropriately the CEO is paid.

See our latest analysis for Exelixis

Advertisement

How Does Michael Morrissey's Compensation Compare With Similar Sized Companies?

According to our data, Exelixis, Inc. has a market capitalization of US$6.4b, and pays its CEO total annual compensation worth US$8.0m. (This figure is for the year to December 2018). We think total compensation is more important but we note that the CEO salary is lower, at US$945k. When we examined a selection of companies with market caps ranging from US$4.0b to US$12b, we found the median CEO total compensation was US$6.9m.

So Michael Morrissey receives a similar amount to the median CEO pay, amongst the companies we looked at. Although this fact alone doesn't tell us a great deal, it becomes more relevant when considered against the business performance.

You can see, below, how CEO compensation at Exelixis has changed over time.

NasdaqGS:EXEL CEO Compensation, July 22nd 2019
NasdaqGS:EXEL CEO Compensation, July 22nd 2019

Is Exelixis, Inc. Growing?

Exelixis, Inc. has increased its earnings per share (EPS) by an average of 118% a year, over the last three years (using a line of best fit). It achieved revenue growth of 46% over the last year.

This demonstrates that the company has been improving recently. A good result. The combination of strong revenue growth with medium-term earnings per share improvement certainly points to the kind of growth I like to see.

Has Exelixis, Inc. Been A Good Investment?

I think that the total shareholder return of 144%, over three years, would leave most Exelixis, Inc. shareholders smiling. So they may not be at all concerned if the CEO were to be paid more than is normal for companies around the same size.

In Summary...

Michael Morrissey is paid around what is normal the leaders of comparable size companies.

Few would be critical of the leadership, since returns have been juicy and earnings per share are moving in the right direction. Although the pay is a normal amount, some shareholders probably consider it fair or modest, given the good performance of the stock. If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Exelixis.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NasdaqGS:EXEL

Exelixis

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Fair Value:US$7.558.3% undervalued
15 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.1% undervalued
53 users have followed this narrative
1 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56053.2% undervalued
62 users have followed this narrative
2 users have commented on this narrative
29 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2781.3% undervalued
30 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

AN
AntonioS
REA logo
AntonioS on REA Group ·

Is REA Group a Good Value Opportunity?

Fair Value:AU$1489.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JO
John_Eric
NOW logo
John_Eric on ServiceNow ·

The Company Nobody Brags About

Fair Value:US$165.6943.4% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AntonioS
ASX logo
AntonioS on ASX ·

ASX Limited

Fair Value:AU$4320.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7445.2% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.6% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17060.0% undervalued
51 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative